Intervene With Jakafi® (ruxolitinib) at the First Sign of Initial Systemic Treatment Failure in Chronic GVHD: A Real-World, Case-Based Discussion iconIntervene With Jakafi® (ruxolitinib) at the First Sign of Initial Systemic Treatment Failure in Chronic GVHD: A Real-World, Case-Based Discussion

Intervene With Jakafi® (ruxolitinib) at the First Sign of Initial Systemic Treatment Failure in Chronic GVHD: A Real-World, Case-Based Discussion

Jan 24, 2023 3:00pm ‐ Jan 24, 2023 4:00pm

Identification: web230124

Speaker(s):

Intervene With Jakafi® (ruxolitinib) at the First Sign of Initial Systemic Treatment Failure in Chronic GVHD: A Real-World, Case-Based Discussion iconIntervene With Jakafi® (ruxolitinib) at the First Sign of Initial Systemic Treatment Failure in Chronic GVHD: A Real-World, Case-Based Discussion

Intervene With Jakafi® (ruxolitinib) at the First Sign of Initial Systemic Treatment Failure in Chronic GVHD: A Real-World, Case-Based Discussion

Jan 25, 2023 12:00pm ‐ Jan 25, 2023 1:00pm

Identification: web230125

Speaker(s):

Intervene With Jakafi® (ruxolitinib) at the First Sign of Initial Systemic Treatment Failure in Chronic GVHD: A Real-World, Case-Based Discussion iconIntervene With Jakafi® (ruxolitinib) at the First Sign of Initial Systemic Treatment Failure in Chronic GVHD: A Real-World, Case-Based Discussion

Intervene With Jakafi® (ruxolitinib) at the First Sign of Initial Systemic Treatment Failure in Chronic GVHD: A Real-World, Case-Based Discussion

Jan 26, 2023 3:00pm ‐ Jan 26, 2023 4:00pm

Identification: web230126

Speaker(s):

Intervene With Jakafi® (ruxolitinib) at the First Sign of Initial Systemic Treatment Failure in Chronic GVHD: A Real-World, Case-Based Discussion iconIntervene With Jakafi® (ruxolitinib) at the First Sign of Initial Systemic Treatment Failure in Chronic GVHD: A Real-World, Case-Based Discussion

Intervene With Jakafi® (ruxolitinib) at the First Sign of Initial Systemic Treatment Failure in Chronic GVHD: A Real-World, Case-Based Discussion

Jan 31, 2023 3:00pm ‐ Jan 31, 2023 4:00pm

Identification: web230131

Speaker(s):

Intervene With Jakafi® (ruxolitinib) at the First Sign of Initial Systemic Treatment Failure in Chronic GVHD: A Real-World, Case-Based Discussion iconIntervene With Jakafi® (ruxolitinib) at the First Sign of Initial Systemic Treatment Failure in Chronic GVHD: A Real-World, Case-Based Discussion

Intervene With Jakafi® (ruxolitinib) at the First Sign of Initial Systemic Treatment Failure in Chronic GVHD: A Real-World, Case-Based Discussion

Feb 1, 2023 12:00pm ‐ Feb 1, 2023 1:00pm

Identification: web230201

Speaker(s):

Discussion of BRUKINSA for adult patients with CLL/SLL iconDiscussion of BRUKINSA for adult patients with CLL/SLL

Discussion of BRUKINSA for adult patients with CLL/SLL

Feb 21, 2023 3:00pm ‐ Feb 21, 2023 4:00pm

Identification: web230221

Speaker(s):

Discussion of BRUKINSA for adult patients with CLL/SLL iconDiscussion of BRUKINSA for adult patients with CLL/SLL

Discussion of BRUKINSA for adult patients with CLL/SLL

Feb 22, 2023 4:00pm ‐ Feb 22, 2023 5:00pm

Identification: web230222

Speaker(s):

Discussion of BRUKINSA for adult patients with CLL/SLL iconDiscussion of BRUKINSA for adult patients with CLL/SLL

Discussion of BRUKINSA for adult patients with CLL/SLL

Feb 23, 2023 3:00pm ‐ Feb 23, 2023 4:00pm

Identification: web230223

Speaker(s):

Discussion of BRUKINSA for adult patients with CLL/SLL iconDiscussion of BRUKINSA for adult patients with CLL/SLL

Discussion of BRUKINSA for adult patients with CLL/SLL

Feb 28, 2023 3:00pm ‐ Feb 28, 2023 4:00pm

Identification: web230228

Speaker(s):

Discussion of BRUKINSA for adult patients with CLL/SLL iconDiscussion of BRUKINSA for adult patients with CLL/SLL

Discussion of BRUKINSA for adult patients with CLL/SLL

Mar 1, 2023 12:00pm ‐ Mar 1, 2023 1:00pm

Identification: web230301

Speaker(s):